Linqi Ouyang
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
-
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immune Response and Inflammation
Papers in
-
- RNA Interference and Gene Delivery 2
- Cell death mechanisms and regulation 1
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Stephen I. Alexander (1 shared paper)Guoping Zheng (1 shared paper)Dan Chang (1 shared paper)Yaming Wang (1 shared paper)Jana Coombs (1 shared paper)Vincent Lee (1 shared paper)David C.H. Harris (1 shared paper)Deepika Mahajan (1 shared paper)
In The Last Decade
Linqi Ouyang
13 papers receiving 447 citations
Peers
Comparison fields: 5 of 87
- Nephrology 98
- Immunology 191
- Genetics 32
- Transplantation 6
- Rehabilitation 14
Countries citing papers authored by Linqi Ouyang
This map shows the geographic impact of Linqi Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linqi Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linqi Ouyang more than expected).
Fields of papers citing papers by Linqi Ouyang
This network shows the impact of papers produced by Linqi Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linqi Ouyang. The network helps show where Linqi Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linqi Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 304 | |
| 2 | 2017 | 61 | |
| 3 | 2021 | 18 | |
| 4 | 2022 | 17 | |
| 5 | 2020 | 15 | |
| 6 | 2013 | 13 | |
| 7 | 2025 | 7 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 4 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2012 | 1 | |
| 14 | 2025 | 0 |
About Linqi Ouyang
Linqi Ouyang is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Biomedical Engineering, having authored 14 papers that have together received 453 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers), Nanoplatforms for cancer theranostics (2 papers), Hepatitis B Virus Studies (1 paper), Liver physiology and pathology (1 paper), Global Healthcare and Medical Tourism (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Nephrology (98 citations), Immunology (191 citations), Genetics (32 citations), Transplantation (6 citations) and Rehabilitation (14 citations). Linqi Ouyang has collaborated with scholars based in China, Australia and Brazil. Frequent co-authors include Stephen I. Alexander, Guoping Zheng, Dan Chang, Yaming Wang, Jana Coombs, Vincent Lee, David C.H. Harris, Deepika Mahajan, Guiming Deng and Shengfeng Wang. Their work appears in journals such as Frontiers in Pharmacology, Expert Opinion on Drug Safety, Journal of Controlled Release, Kidney International and Drug Discoveries & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.